Posterior Wall Isolation Via a Multi-electrode Radiofrequency Balloon Catheter: Feasibility, Technical Considerations, Endoscopic Findings and Comparison with Cryoballoon Technologies
Overview
Authors
Affiliations
Background: Posterior wall (PW) isolation is an important adjunctive ablation target in patients with non-paroxysmal atrial fibrillation (AF). Traditionally performed with point-by-point radiofrequency (RF) ablation, PW isolation has also been performed with different cryoballoon technologies. We aimed at assessing the feasibility of PW isolation with the novel RF balloon catheter Heliostar™ (Biosense Webster, CA, USA).
Methods: We prospectively enrolled 32 consecutive patients with persistent AF scheduled for first-time ablation with the Heliostar™ device. Procedural data were compared with those from 96 consecutive persistent AF patients undergoing pulmonary vein (PV) plus PW isolation with a cryoballoon device. The ratio RF balloon/cryoballoon was 1:3 for each operator involved in the study, aiming at avoiding any imbalance related to different experience.
Results: Single-shot PV isolation was documented in a significantly higher number of cases with the RF balloon technology compared to cryoballoon ablation (89.8% vs. 81.0%; p = 0.02, respectively). PW isolation was achieved with a similar number of balloon applications between the two groups (11 ± 4 with the RF balloon versus 11 ± 2 with the cryoballoon; p = 0.16), but in a significantly shorter time among RF balloon patients (228 ± 72 s versus 1274 ± 277 s with cryoballoon; p < 0.001). Primary safety endpoint occurred in none of the RF balloon patients versus 5 (5.2%) patients in the cryoballoon group (p = 0.33). Primary efficacy endpoint was achieved in all (100%) RF balloon patients versus 93 (96.9%) cryoballoon ones (p = 0.57). Oesophageal endoscopy did not show any signs of thermal lesions in RF balloon patients with luminal temperature rise.
Conclusions: RF balloon-based PW isolation was safe and promoted shorter procedure times compared to similar cryoballoon-based ablation procedures.
Vetta G, Della Rocca D, Parlavecchio A, Magnocavallo M, Sorgente A, Pannone L Europace. 2024; 26(12).
PMID: 39579376 PMC: 11641428. DOI: 10.1093/europace/euae293.
Della Rocca D, Marcon L, Magnocavallo M, Mene R, Pannone L, Mohanty S Europace. 2024; 26(1).
PMID: 38245007 PMC: 10823352. DOI: 10.1093/europace/euae016.
Teumer Y, Miesbichler C, Hauke A, Katov L, Bothner C, Pott A J Clin Med. 2024; 13(1).
PMID: 38202216 PMC: 10779570. DOI: 10.3390/jcm13010207.
Zylla M, Starrach L, Rahm A, Thomas D, Frey N, Lugenbiel P Front Cardiovasc Med. 2023; 10:1208250.
PMID: 38034374 PMC: 10682364. DOI: 10.3389/fcvm.2023.1208250.
Berruezo A, Penela D, Jauregui B, de Asmundis C, Peretto G, Marrouche N Europace. 2023; 25(8).
PMID: 37622578 PMC: 10450789. DOI: 10.1093/europace/euad183.